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background:  Imaging techniques may contribute to the proper risk assessment of patients with coronary artery disease (CAD). Especially, cardiac 
magnetic resonance imaging (CMR) is able to provide important prognostic information by detection of myocardial scarring (late gadolinium 
enhancement, LGE) and reversible ischemia. Therefore, objective of the present study was to quantify the extent of global ischemic burden by the 
combination of LGE and reversible ischemia by CMR and to correlate the results with long-term outcome and prognosis in patients with known or 
suspected CAD.
methods:  Consecutive patients referred for CMR imaging were prospectively screened and enrolled from 2003 to 2007. Besides functional and 
volumetric assessment, adenosine perfusion and LGE imaging were performed on a 1.5 T whole-body scanner. Global ischemic burden was assessed 
and quantified by combination of reversible ischemia and LGE. Primary endpoint was defined as cardiac death, nonfatal myocardial infarction or 
stroke.
results:  Our study population consisted of 845 consecutive patients. Mean follow-up was 4.1 ± 1.8 years. During this time, 61 primary endpoints 
occurred. A cutoff for global ischemic burden of 36% was defined by ROC analysis. A primary endpoint occurred in 15 patients who exhibited an 
ischemic burden higher than the cutoff (event rate of 33%). In contrast, a primary endpoint could be observed in only 5.1% (41) of patients with a 
low or absent ischemic burden. On multivariate analysis, an ischemic burden higher than the cutoff was the strongest independent predictor for the 
occurrence of a primary endpoint with a hazard ratio of 3.4.
conclusions:  Global ischemic burden can easily be assessed and quantified by the provided CMR algorithm. An ischemic burden >=36% is 
strongly associated with the occurrence of major clinical adverse events and thus owns important prognostic value.
